TWD 32.3
(1.1%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -4.45 Million TWD | -83.29% |
2022 | 38.15 Million TWD | 535.18% |
2021 | 6 Million TWD | 1831.51% |
2020 | 311 Thousand TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 FY | 6.37 Million TWD | -83.29% |
2022 FY | 38.15 Million TWD | 535.18% |
2021 FY | 6 Million TWD | 1831.51% |
2020 FY | 311 Thousand TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
BIONET Corp. | 84.69 Million TWD | 105.258% |
DIVA Laboratories, Ltd. | 92.15 Million TWD | 104.832% |
Genetics Generation Advancement Corp. | 18.57 Million TWD | 123.972% |
Welgene Biotech Co.,Ltd. | -4.25 Million TWD | -4.555% |
Puriblood Medical Co., Ltd. | -50.4 Million TWD | 91.165% |